8 completed. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 3 | Completed 3 |
Follow ForSight Vision5, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Fixed Combination, Bimatoprost, Timolol - Open-Angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | Completed | ForSight Vision5, Inc. | 55 | 2016-04-30 | 2019-02-25 |
| An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert Bimatoprost - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 81 | 2015-08-10 | 2019-04-02 |
| Bimatoprost Ocular Insert Pharmacokinetic Study 13mg Bimatoprost Ocular Insert - Healthy Volunteers | Phase 1 | Completed | ForSight Vision5, Inc. | 11 | 2015-03-01 | 2015-05-14 |
| Dose-Ranging Study of the Bimatoprost Ocular Insert Bimatoprost, Timolol 0.5%, Placebo Ocular Insert - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 156 | 2015-01-19 | 2020-06-04 |
| Survey of Patients Taking IOP-Lowering Eye Drops Survey - Glaucoma, Ocular Hypertension | Completed | ForSight Vision5, Inc. | 160 | 2015-01-01 | 2015-06-11 | |
| An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product Bimatoprost - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 75 | 2014-06-05 | 2019-02-26 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension Bimatoprost, Timolol 0.5%, Placebo Eye Drops - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 169 | 2013-10-23 | 2018-04-20 |
| A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension VISION5 Product - Ocular Hypertension, Primary Open Angle Glaucoma | Phase 1 | Completed | ForSight Vision5, Inc. | 14 | 2013-10-01 | 2014-12-17 |
Ocular Hypertension (7) · Glaucoma, Open-Angle (6) · Glaucoma (2)
Bimatoprost (5) · Timolol (2) · Surveys and Questionnaires (1)
United States (6) · Latvia (1) · Panama (1)
Michelle Chen, PhD (5) · Anne Rubin (1) · Gary Walker, PhD (1)